Literature DB >> 9731987

Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infection.

D Y Graham1, M S Osato, C A Olson, J Zhang, N Figura.   

Abstract

BACKGROUND: It has been suggested that H. pylori infection is associated with abnormalities in total leukocyte count as well as the number of basophils and lymphocytes. In addition, CagA seropositivity has been associated with an increase in serum transaminase (SGOT) values. The aim of this study was to confirm the findings of previous subgroup analyses in patients before and after treatment for H. pylori infection and to ascertain whether the abnormalities reversed following successful treatment.
METHODS: Blood counts and serum transaminase levels were obtained prior to and following treatment of H. pylori infection of H. pylori-infected duodenal ulcer patients. CagA status was assessed by Western blot of the H. pylori isolates obtained from the patients.
RESULTS: Ninety-four ulcer patients were studied, including 77 with CagA-positive H. pylori isolates (82%) and 17 with CagA-negative H. pylori isolates. All study parameters remained within normal limits both before and after therapy. There were no significant changes in any study parameter in those who failed therapy. Successful therapy resulted in a significant fall in total white cell count (7413 +/- 520 cmm to 6738 +/- 410 cmm, for pretreatment vs. cured, respectively, p = 0.04) and was almost entirely accounted for by a reduction in the number of circulating polymorphonuclear leukocytes (4595 +/- 370 cmm to 3855 +/- 270 cmm for pretreatment vs. cured, respectively, p = 0.015). The pretreatment SGOT and basophil count were significantly higher in those with CagA-positive H. pylori (SGOT = 23 +/- 1 vs. 18.5 +/- 1 U). Successful or failed therapy with follow-up for 3 months post therapy did not result in a significant change of SGOT levels.
CONCLUSIONS: We confirmed an increase in total leukocyte count and number of polymorphonuclear leukocytes in those with H. pylori infection. We also confirmed higher SGOT levels with CagA-positive H. pylori infection, but the failure to resolve within 3 months of cure of the infection makes it unlikely to be a direct result of the H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731987     DOI: 10.1046/j.1523-5378.1998.08018.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  18 in total

1.  H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.

Authors:  Cristina Lenzi; Alberto Palazzuoli; Nicola Giordano; Giuliano Alegente; Catia Gonnelli; Maria-Stella Campagna; Annalisa Santucci; Michele Sozzi; Panagiotis Papakostas; Fabio Rollo; Ranuccio Nuti; Natale Figura
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

2.  Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Annalisa Piazzese; Antonio Ponzetto; Tullia Todros
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

3.  Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls.

Authors:  N Figura; L Gennari; D Merlotti; C Lenzi; S Campagna; B Franci; B Lucani; L Trabalzini; L Bianciardi; C Gonnelli; A Santucci; A Nut
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

Review 4.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

5.  Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalities.

Authors:  N Figura; A Palazzuoli; S Faglia; C Lenzi; F Borrello; V Palazzuoli; R Nami; N Dal Canto; F De Regis; D Vaira; L Gennari; N Giordano; C Gennari
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis.

Authors:  Alyssa M Krasinskas; Yuan Yao; Parmjeet Randhawa; Maria P Dore; Antonia R Sepulveda
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

7.  Infection by CagA-positive Helicobacter pylori strains may contribute to alter the sperm quality of men with fertility disorders and increase the systemic levels of TNF-alpha.

Authors:  Giulia Collodel; Elena Moretti; Maria Stella Campagna; Serena Capitani; Cristina Lenzi; Natale Figura
Journal:  Dig Dis Sci       Date:  2009-01-22       Impact factor: 3.199

Review 8.  Helicobacter pylori infection and endocrine disorders: is there a link?

Authors:  Konstantinos X Papamichael; Garyphallia Papaioannou; Helen Karga; Anastasios Roussos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

Review 9.  Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact?

Authors:  Waleed I Albaker
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

10.  Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis.

Authors:  Mervat M El-Eshmawy; Amany K El-Hawary; Soma S Abdel Gawad; Azza A El-Baiomy
Journal:  Diabetol Metab Syndr       Date:  2011-10-26       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.